'Trial participants' presentation slideshows

Recruitment to Trials

Recruitment to Trials. Background. Recruitment of participants is a VERY important issue. The general consensus is that most trials under recuit. Poor Recruitment. Poor or slow recruitment to trials leads to the following problems:

522 views • 35 slides

www.icad-cisd.com

www.icad-cisd.com. New Prevention Technologies Workshop Module 7: Media Analysis. interpreting trial results. Trial Size. One statistical calculation that occurs before a trial begins is the sample size or the number of volunteers that need to be enrolled.

423 views • 29 slides

Ethics and Clinical Trials in Resource Limited Settings

Ethics and Clinical Trials in Resource Limited Settings. George M. Carter, Director, Foundation for Integrative AIDS Research (FIAR), Brooklyn, NY, USA. Overview. Academic Cultural Political Intersections and Actions. Ethical Guidelines.

448 views • 26 slides

Manju Chatani, AMAG Anna Forbes, GCM M2008 Pre-Conference Advocates Workshop 24 February, 2008

339 views • 23 slides

Regulatory Implications of The WHI Study

Regulatory Implications of The WHI Study. Eric Colman, MD Center for Drug Evaluation and Research Division of Metabolic and Endocrine Drugs October 7, 2003. Outline. Terminology Regulatory history of estrogens and estrogen + progestin formulations

382 views • 21 slides

STEP - Strategic Deployment throughout the Industry Supply Chain

STEP - Strategic Deployment throughout the Industry Supply Chain. A Perspective from Downunder NASA - JPL STEP Workshop - Jan 2001 Martin Jones - mjones@ausdec.com.au www.ausdec.com.au ef : DRMAUSDECausap_presentation.ppt.

293 views • 20 slides

STEP - Strategic Deployment throughout the Industry Supply Chain

STEP - Strategic Deployment throughout the Industry Supply Chain. A Perspective from Downunder NASA - JPL STEP Workshop - Jan 2001 Martin Jones - mjones@ausdec.com.au www.ausdec.com.au ef : DRMAUSDECausap_presentation.ppt.

208 views • 20 slides

Data Monitoring Committees

Data Monitoring Committees. What is it?. =DSMB, IDMC, DRB, etc. EMEA guideline, Jan 2006 A group of independent experts external to a study assessing the progress, safety data and, if needed, critical endpoints of a clinical trials. Power of DMC.

278 views • 15 slides

Current status of policies of care provision in HIV prevention trials

Current status of policies of care provision in HIV prevention trials. Catherine Hankins Associate Director, Strategic Information and Chief Scientific Advisor to UNAIDS. Geneva, June 21, 2005. 2000 Guidelines. July 2003 Intercurrent infections. World Bank

261 views • 14 slides

Thorny Issues in HIV Vaccine Trials

Thorny Issues in HIV Vaccine Trials. Saul Walker Policy Advisor IAVI. Thorny Issues?. Vaccine positivity (including insurance) Clades Partial efficacy and end-points Cohort selection Phase 2b or not Phase 2b Placebo selection

275 views • 14 slides

The Tenofovir Trial in Cambodia

The Tenofovir Trial in Cambodia.

226 views • 9 slides

Indicators of Successful Community Participation

Indicators of Successful Community Participation. Africa Regional Working Group 20 May 2003 Stella Kirkendale & Wayne Wilson. Overview. How do we measure effectiveness? The science of community participation UCSF Survey effort CWG Ethics Guidance Document effort

532 views • 8 slides

Informed Consent in Clinical Trials (CT)

Clinical Research is a most knowledge-intensive and interesting field in the pharmaceutical industry.

36 views • 3 slides

Electronic data capture cloud edc system

Infoset provides most advance Electronic Data Capture (EDC) systems included with cloud based EDC

244 views • 1 slides